EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overestimation of clinical N-staging in microsatellite instable gastric cancers is associated with VEGF-C signaling and CD8+ T-cell dynamics

Chun-Yi Tsai, Tzong-Shyuan Tai, Shih-Chiang Huang, Tsung-Hsing Chen, Jun-Te Hsu, Chun-Nan Yeh, Ying-Chieh Lai, Gigin Lin, Ta-Sen Yeh iD

The Oncologist · 2025

DOI: 10.1093/oncolo/oyae288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Chun-Yi Tsai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan 333, Taiwan. Hauptthemen laut MEDLINE: Stomach Neoplasms, CD8-Positive T-Lymphocytes, Microsatellite Instability, Vascular Endothelial Growth Factor C. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chang Gung Medical Research Program, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Microsatellite instable (MSI) gastric cancers exhibit reduced lymph node (LN) metastasis and improved survival compared to microsatellite stable (MSS) counterparts. However, to our longstanding observation, clinical N-staging (cN) is frequently overestimated in MSI cases. The clinical implications and underlying mechanisms of this discrepancy warrant further investigation. Materials and methods We conducted a comprehensive review of clinicopathological data from a 141 MSI and 1119 MSS gastric cancer patients. Expression of vascular endothelial growth factor-C (VEGF-C) and its receptor VEGFR-3 were assessed using qPCR and immunohistochemistry. High-parameter flow cytometry was employed to analyze subsets of CD8+ T cells within the tumors.

Results

Multivariate analysis revealed that MSI status was an independent prognostic factor, alongside the LN ratio and AJCC8 pathology staging. MSI gastric cancers exhibited a reduced LN ratio, particularly at advanced T-staging, compared to MSS counterparts, while maintaining an equivalent LN yield. Overestimation of cN by computed tomography preoperatively was frequent in MSI gastric cancers but was more commonly underestimated in MSS counterparts. VEGF-C and VEGFR-3 expression were lower in MSI tumors. MSI gastric cancers showed an increased total number of CD8+ T cells, albeit with a lower proportion of effector memory cells expressing CD45RA (EMRA) and CD8+ CXCR4+ T cells, compared to MSS counterparts.

Conclusion

Frequent overestimation of clinical N-staging in MSI gastric cancers is associated with VEGF-C signaling and CD8+ T-cell dynamics and should be cautiously interpreted, as it might misguide therapeutic options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsCD8-Positive T-LymphocytesMicrosatellite InstabilityVascular Endothelial Growth Factor CHumansFemaleMaleMiddle AgedNeoplasm StagingAgedSignal TransductionPrognosisVascular Endothelial Growth Factor Receptor-3Lymphatic MetastasisAdult

Stichwörter der Autor:innen

CD8+ T cellVEGF-Cclinical N-staginglymph node ratiomicrosatellite instable gastric cancer

Substanzen

Vascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-3VEGFC protein, human

Autor:innen und Institutionen

  • Department of Surgery, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan 333, Taiwan.
  • Department of Medical Research and Development, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan 333, Taiwan.
  • Department of Pathology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan 333, Taiwan.
  • Department of Gastroenterology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan 333, Taiwan.
  • Department of Radiology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan 333, Taiwan.

ORCID-Profile: Ta-Sen Yeh

Förderung

  • Chang Gung Medical Research Program, Taiwan

Zitieren

APA

Tsai, C. Y., Tai, T. S., Huang, S. C., Chen, T. H., Hsu, J. T., Yeh, C. N., Lai, Y. C., Lin, G., & Yeh, T. S. (2025). Overestimation of clinical N-staging in microsatellite instable gastric cancers is associated with VEGF-C signaling and CD8+ T-cell dynamics. The Oncologist. https://doi.org/10.1093/oncolo/oyae288

Vancouver

Tsai CY, Tai TS, Huang SC, Chen TH, Hsu JT, Yeh CN, et al. Overestimation of clinical N-staging in microsatellite instable gastric cancers is associated with VEGF-C signaling and CD8+ T-cell dynamics. The Oncologist. 2025. doi:10.1093/oncolo/oyae288

BibTeX
@article{Tsai2025,
  author = {Tsai, Chun-Yi and Tai, Tzong-Shyuan and Huang, Shih-Chiang and Chen, Tsung-Hsing and Hsu, Jun-Te and Yeh, Chun-Nan and Lai, Ying-Chieh and Lin, Gigin and Yeh, Ta-Sen},
  title = {Overestimation of clinical N-staging in microsatellite instable gastric cancers is associated with VEGF-C signaling and CD8+ T-cell dynamics},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyae288}
}
Kostenlos starten →